| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.36 | 6e-17 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-14 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-12 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-08 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |